Abundant extracellular products and methods for their production and use
OwnerMarcus A. Horwitzinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerMarcus A. Horwitzinventor
Estimating the term…
Vaccines based on one or more combinations of majorly abundant extracellular products of pathogens and methods for their use and production are presented. The most prevalent or majorly abundant extracellular products of a target pathogen are selected irrespective of their absolute molecular immunogenicity and used as vaccines to stimulate a protective immune response in mammalian hosts against subsequent infection by the target pathogen. The majorly abundant extracellular products may be characterized and distinguished by their respective N-terminal amino acid or DNA sequences. As the vaccines may comprise different combinations of the extracellular products, subunits thereof, or encoding nucleic acids, a broad range of effective immunotherapeutic compositions are provided by the present invention. In addition to other infectious agents, the vaccines so produced can be used to stimulate an effective immune response against intracellular pathogens and in particular Mycobacterium tuberculosis.
A vaccinating agent for use in promoting an effective immune response, in a mammalian host, against an infectious pathogen from the genus Mycobacterium, said vaccinating agent comprising:
An immunodiagnostic agent for use in promoting a detectable immune response in a mammalian host identifying an infectious pathogen from the genus Mycobacterium, said immunodiagnostic agent comprising:
A method of immunizing a mammalian host against an infectious pathogen of the genus Mycobacterium, said method comprising the steps of:
A method for detecting the presence of an immune response in a mammal against a pathogen of the genus Mycobacterium, said method comprising the steps of:
Dependencies are inferred from the claim text.